News & Trends - MedTech & Diagnostics
ASO warns against US-style managed care as ACCC considers authorising buying group
MedTech News: The private health insurers lobby regularly with the Federal Government claiming a crisis of affordability in private health insurance and request for increased funding and regulatory changes designed to control the private healthcare sector.
In an interview with Health Industry Hub, Dr Peter Sumich, Vice President, Australian Society of Ophthalmologists (ASO), provided his views on health insurers seeking to enter the ownership of private medical and surgical facilities in Australia. He detailed the adverse impact of US-style managed care on clinicians, clinical practice and patient care, if this was to be adopted locally.
In light of the recent ACCC issued draft determination to authorise Honeysuckle Health (Cigna/nib health funds) to form a health services buying group, the ASO has launched an awareness campaign to alert Australians to the dangers of US-style managed healthcare and the potential adverse consequences for insured patients.
“This is another paradigm shifting moment where we have to see that this partnership between Cigna and nib is an inch too far,” stated Dr Sumich.
The ACCC draft recommendation allows for 40% of the Australian marketplace to be consumed by this joint venture, which will force other insurers to respond. Insurers can minimise payouts by organising discount health packages through bundling the doctor, hospital and treatment plan which they contract together based on minimal costs.
Managed care is very profitable for health insurers but can be disastrous for patients as experience in the US shows.
The ASO and other medical bodies including the AMA will attempt to persuade the Federal Government to protect privately insured patients by strengthening the Health Act and introducing anti-managed care legislation.
Contact your Local Federal Member. You may download the ASO template, change the text or add to it to personalise and send via email or post.
News & Trends - MedTech & Diagnostics
Inaugural summit demands government action for overburdened public hospitals
MedTech & Diagnostics News: Leaders from more than 50 of Australia’s medical institutions convened in Canberra yesterday. The mission: to […]
MoreNews & Trends - Pharmaceuticals
Doubling risk of bowel cancer diagnosis before 40 sparks action
Pharma News: Bowel Cancer Australia, in collaboration with co-chairs Steve Georganas MP and the Hon Dr David Gillespie MP, has […]
MoreNews & Trends - Pharmaceuticals
Immunisation Coalition sounds alarm on influenza season
Pharma News: Australia could be on the cusp of yet another early and severe influenza season in 2024, raising concerns […]
MoreNews & Trends - MedTech & Diagnostics
Is there a policy reform black hole in the private health sector?
MedTech & Diagnostics News: Australia’s private hospitals are facing a crisis of sustainability. Despite accounting for a significant portion of […]
More